Gilliland Jeter Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Buy
1,603
+11
+0.7% +$11.2K 0.5% 55
2026
Q1
$1.46M Buy
1,592
+15
+1% +$15.2K 0.43% 56
2025
Q4
$1.69M Buy
1,577
+2
+0.1% +$1.91K 0.51% 48
2025
Q3
$1.2M Buy
1,575
+32
+2% +$23.8K 0.37% 58
2025
Q2
$1.2M Buy
1,543
+319
+26% +$248K 0.39% 56
2025
Q1
$1.01M Hold
1,224
0.36% 63
2024
Q4
$945K Sell
1,224
-101
-8% -$83.6K 0.32% 70
2024
Q3
$1.17M Hold
1,325
0.38% 57
2024
Q2
$1.2M Buy
1,325
+237
+22% +$190K 0.4% 58
2024
Q1
$846K Sell
1,088
-66
-6% -$47K 0.29% 75
2023
Q4
$673K Buy
+1,154
New +$674K 0.28% 88

Other funds holding LLY

Gilliland Jeter Wealth Management's LLY Position: Q2 2026 in Review

Gilliland Jeter Wealth Management increased its Eli Lilly (LLY) stake by 0.69% in Q2 2026, buying an estimated $11.2K and bringing the position to 1,603 shares worth $1.92M. The position accounts for 0.5% of the portfolio, ranked #55.

Gilliland Jeter Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gilliland Jeter Wealth Management held 1,603 shares of Eli Lilly worth $1.92M as of Q2 2026.
  • Gilliland Jeter Wealth Management bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.5% of Gilliland Jeter Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Gilliland Jeter Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gilliland Jeter Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.